Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN9A | Q15858 | 11/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.42 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.38 |
| ▸ | HTR6 | P50406 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13335079 | 0.84 | NR4A2 (0.50) | SCN9AKDM4ENR4A2POLBCTDSP1 | |
| SCHEMBL10323800 | 0.78 | NR4A2 (0.40) | SCN9AKDM4ENR4A2POLBCTDSP1 | |
| SCHEMBL28878338 | 0.74 | NR4A2 (0.55) | KDM4ENR4A2POLBCTDSP1HTR6 | |
| SCHEMBL10325497 | 0.73 | KDM4E (0.51) | KDM4ENR4A2POLBCTDSP1HTR6 | |
| SCHEMBL700645 | 0.69 | KDM4E (0.40) | SCN9AKDM4ENR4A2POLBCTDSP1 | |
| SCHEMBL5998891 | 0.68 | LTA4H (0.50) | L3MBTL1ALDH1A1 | |
| SCHEMBL20101801 | 0.68 | NR4A2 (0.40) | SCN9AKDM4ENR4A2POLBCTDSP1 | |
| SCHEMBL7431522 | 0.68 | NR4A2 (0.56) | SCN9AKDM4ENR4A2ALDH1A1 | |
| SCHEMBL31744892 | 0.67 | LTA4H (0.39) | SCN9AKDM4EPOLBATMALDH1A1 | |
| SCHEMBL20101800 | 0.67 | NR4A2 (0.69) | KDM4ENR4A2L3MBTL1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9382206-B2 | Nitrogen-containing aromatic heterocyclic derivative and organic electroluminescence device using the same | IDEMITSU KOSAN CO., LTD. (JP) | 2016-07-05 | — | — | US | disclosed |
| EP-2628729-A1 | AROMATIC HETEROCYCLIC DERIVATIVE, AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME | Idemitsu Kosan Co., Ltd. (JP) | 2013-08-21 | — | — | EP | disclosed |
| EP-2617712-A1 | NITROGEN-CONTAINING AROMATIC HETEROCYCLIC DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING SAME | Idemitsu Kosan Co., Ltd. (JP) | 2013-07-24 | — | — | EP | disclosed |
| US-20120273766-A1 | AROMATIC HETEROCYCLIC DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2012-11-01 | — | — | US | disclosed |
| US-20120181524-A1 | NITROGEN-CONTAINING AROMATIC HETEROCYCLIC DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2012-07-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120181524-A1 | NITROGEN-CONTAINING AROMATIC HETEROCYCLIC DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | AOC3, NPR3, NR0B1 | SCN9A 1329/4885KDM4E 3595/4885NR4A2 43/4885 |
| US-20120273766-A1 | AROMATIC HETEROCYCLIC DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | DDC, ODC1, TYR | SCN9A 1289/4885KDM4E 1308/4885NR4A2 1477/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.